Skip to main content
. 2017 Mar 14;8(20):32706–32721. doi: 10.18632/oncotarget.16188

Figure 1. Carbenoxolone as an HMGB1 blocker and cell migration inhibitor.

Figure 1

(A) Transwell assay of LLC cells after 21 hours of incubation with ranging concentrations of Carbenoxolone, presenting dose response migration. n = 6. (B–C) Scratch assays at t0 and after 16 hours of incubation with ranging concentrations of Carbenoxolone. White thin lines present the scratch area. (B) LLC cells were incubated with lower concentrations than (C) MDA-MB-231 cells. At t0 inserts were removed and 16 hours later pictures were taken of both LLC and MDA-MB-231. n = 3. **p ≤ 0.01, ***p ≤ 0.001.